Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,485
Total Claims
$957K
Drug Cost
885
Beneficiaries
$1,082
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-39%
Opioid rate vs peers
1.6% vs 2.6% avg
+1%
Cost per patient vs peers
$1,082 vs $1,068 avg
+38%
Brand preference vs peers
12.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.6%
Opioid Rate
164
Opioid Claims
$1,735
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,288 claims · $785K
Generic: 9,070 claims · $167K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 89 | $118K |
| Apixaban | 86 | $89K |
| Insulin Glargine,hum.Rec.Anlog | 108 | $73K |
| Dulaglutide | 35 | $70K |
| Fluticasone/Umeclidin/Vilanter | 32 | $35K |
| Sitagliptin Phosphate | 16 | $28K |
| Empagliflozin | 24 | $27K |
| Fluticasone/Vilanterol | 22 | $23K |
| Mirabegron | 28 | $22K |
| Dapagliflozin Propanediol | 20 | $20K |
| Rivaroxaban | 20 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 30 | $18K |
| Budesonide/Formoterol Fumarate | 31 | $17K |
| Fluticasone Propion/Salmeterol | 30 | $11K |
| Linaclotide | 14 | $9,366 |
Prescribing Profile
Patient Profile
75
Avg Age
51%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About